Current Research Projects

1. Captivate: The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Chief Investigator: Prof Sunil Badve

2. ARCTIC: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High blood pressure (BaxDuo-Arctic)

           Chief Investigator: Prof Sunil Badve

 3.BEAT-Calci: Better Evidence And Translation for Calciphylaxis  

Chief Investigator: Dr Brendan Smyth

4. Renal Lifecycle- A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease

Chief Investigator: Dr Brendan Smyth

5. Beyond: A Phase 3, Randomized, Double-blind, Placebo controlled Study of BION-1301 in Adults with IgA Nephropathy

Chief Investigator: Prof Sunil Badve

6. TRACK : Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced Chronic Kidney disease

Chief Investigator: Dr Brendan Smyth

7. REGEN:A phase 3 randomized controlled study of renal autologous cell therapy (REACT) in subjects with type 2 diabetes and chronic kidney disease

Chief Investigator: Prof Sunil Badve

8. Imagination: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE‑BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO7434656, AN                                         ANTISENSE INHIBITOR OF COMPLEMENT FACTOR B, IN PATIENTS WITH PRIMARY IgA NEPHROPATHY AT HIGH RISK OF PROGRESSION

Chief Investigator: Prof Sunil Badve

Please contact Saiyini Pirabhahar for further information on above studies 9113 2484